As Bio­haven CEO Coric preps FDA fil­ing for new mi­graine spray, he's al­ready scout­ing for celebri­ty spokesper­son

Days af­ter re­port­ing pos­i­tive Phase III re­sults for in­tranasal mi­graine med za­veg­epant, Bio­haven chair­man and CEO Vlad Coric is talk­ing about mar­ket­ing plans. It’s a …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER